Non-alcoholic fatty liver disease in chronic hepatitis B patients

References (5)

1. Kim K, Kim KH, Kim HH, Cheong J. Hepatitis B virus X protein in- duces lipogenic transcription factor SREBP1 and fatty acid syn- thase through the activation of nuclear receptor LXRalpha. Bio- chem J 2008 1; 416: 219-30.
2. Zhang Z, Pan Q, Duan X-Y, et al. Fatty liver reduces hepatitis B vi- rus replication in a genotype B hepatitis B virus transgenic mice model. J Gastroenterol Hepatol 2012; 27: 1858-64.
3. Poortahmasebi V, Alavian SM, Keyvani H, Norouzi M, Mahmoodi M, Jazayeri SM. Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pac J Cancer Prev 2014; 15: 3879-84.
4. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437-43.
5. Ceylan B, Arslan F, Batırel A, et al. Impact of fatty liver on hepatitis B virüs replication and virolojik response to tenofovir and enteca- vir. Turk J Gastroenterol 2016; 27: 42-6. 396 Turk J Gastroenterol 2016; 27: 395-6 Let